Plus   Neg

Stock Alert: Kala Pharmaceuticals Falls 11% On Lower Rating

Shares of Kala Pharmaceuticals, Inc. (KALA) are losing almost 11 percent or $0.94 in Monday's morning trade at $7.83 after a rating downgrade by analysts at Jefferies Financial Group.

According to reports, Jefferies downgraded Kala Pharmaceuticals from a 'buy' rating to a 'hold' rating and lowered the price target on the company's stock from $21 to $10.

Kala Pharmaceuticals has traded in a range of $3.24 to $14.68 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Consumers plan to spend less overall on gifts, holiday items, and non-gift purchases for themselves this holiday season, according to an annual survey by the National Retail Federation and Prosper Insights & Analytics. The survey also found that one in five, or 19 percent of holiday shoppers who typically travel for the holidays, prefer to remain at home this year due to the coronavirus pandemic. Microsoft is in agreement with Alaska Airlines to enable flying more sustainably on three most popular routes traveled by Microsoft employees on Alaska Airlines, which uses sustainable aviation fuel (SAF). The SAF, supplied by SkyNRG, is an important option for the aviation industry to reduce carbon (CO2) emissions on a life-cycle basis. Walmart and Sam's Club announced options for customers to safely dispose unused, unwanted and expired medication throughout the year. With this, the retail giant aims to help the public from potential danger for misuse and abuse of prescription medications. On Saturday, October 24, the company will host in-person medication disposal events at select store and club locations across U.S.
Follow RTT